Browsing Tag
Heart Attack
12 posts
Heart attacks can strike suddenly—do you know how to respond?
A heart attack, medically referred to as a myocardial infarction, is a life-threatening condition that demands urgent attention.…
January 12, 2025
Renowned Tamil actor Daniel Balaji passes away at 48
In a sorrowful turn of events, the Tamil film industry has lost one of its celebrated actors, Daniel…
March 30, 2024
Farxiga : AstraZeneca gets FDA fast track status for heart failure after MI
AstraZeneca has secured fast track designation for Farxiga (dapagliflozin) in the US for its use in reducing the…
July 20, 2020
Lilly bags Trulicity FDA approval for reducing CV risk in type 2 diabetes patients
Trulicity FDA approval : Eli Lilly and Company (Lilly) has secured approval from the US Food and Drug…
February 22, 2020
CytoSorbents gets CytoSorb EU approval for removal of ticagrelor during CPB
CytoSorbents has secured approval from the European Union (EU) for its CytoSorb extracorporeal blood purification therapy for the…
February 9, 2020
Amarin bags Vascepa FDA approval for reducing cardiovascular risk
Vascepa FDA approval : New Jersey-based Amarin has secured approval from the US Food and Drug Administration (FDA)…
December 16, 2019
Common signs of heart attack in women not to ignore
All knew that chest pain is the common signs of heart attack. In the real life the common…
May 23, 2019
Wayne Pharmaceuticals launches Dr Wayne’s Aspirin in US
Wayne Pharmaceuticals has launched Dr Wayne’s Aspirin Tablets in the US in a bottle package containing 300 tablets,…
April 27, 2019
Regeneron and Sanofi’s Praluent gets European approval for reducing cardiovascular risk in atherosclerotic disease patients
Regeneron Pharmaceuticals and Sanofi have received a significant boost with the European Commission’s (EC) approval of Praluent (alirocumab)…
March 24, 2019
Lycopene Uses for Cardiovascular Diseases | Tomato Health Benefits
As per the research done by the scientists of Cambridge Theranostics Ltd, a biotech firm, lycopene pigment present…
April 20, 2018